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Significant evidence implicates the endogenous opioid system (EOS) (opioid peptides
and receptors) in the mechanisms underlying the psychopharmacological effects of
ethanol. Ethanol modulates opioidergic signaling and function at different levels, including
biosynthesis, release, and degradation of opioid peptides, as well as binding of
endogenous ligands to opioid receptors. The role of β-endorphin and μ-opioid receptors
(OR) have been suggested to be of particular importance in mediating some of
the behavioral effects of ethanol, including psychomotor stimulation and sensitization,
consumption and conditioned place preference (CPP). Ethanol increases the release
of β-endorphin from the hypothalamic arcuate nucleus (NArc), which can modulate
activity of other neurotransmitter systems such as mesolimbic dopamine (DA). The
precise mechanism by which ethanol induces a release of β-endorphin, thereby inducing
behavioral responses, remains to be elucidated. The present review summarizes
accumulative data suggesting that the first metabolite of ethanol, the psychoactive
compound acetaldehyde, could participate in such mechanism. Two lines of research
involving acetaldehyde are reviewed: (1) implications of the formation of acetaldehyde
in brain areas such as the NArc, with high expression of ethanol metabolizing enzymes
and presence of cell bodies of endorphinic neurons and (2) the formation of condensation
products between DA and acetaldehyde such as salsolinol, which exerts its actions via OR.
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ETHANOL AND THE OPIOID SYSTEM
Evidence indicates that ethanol modulates the activity of different
components of the endogenous opioid system (EOS), with a large
body of data supporting the implication of opioid ligands and
receptors in the mediation of some of the psychopharmacological
effects of ethanol.
THE ENDOGENOUS OPIOID SYSTEM AT A GLANCE
The opioid peptide precursors proopiomelanocortin (POMC),
proenkephalin (PENK) or prodynorphin (PDYN) (Kieffer and
Gavériaux-Ruff, 2002) are the source for the respective peptides
β-endorphin, enkephalin, and dynorphin (Nylander and Roman,
2012). These endogenous ligands activate G-protein-coupled
μ-, ∂-, and κ-opioid receptors (OR) (μ-OR, ∂-OR and κ-
OR), which differ in their affinities and response profiles
(Evans et al., 1992; Knapp et al., 1995; Kieffer and Evans, 2009).
β-endorphin presents higher affinity for μ- than ∂-, and reduced
affinity for κ-OR (Roth-Deri et al., 2008; Trigo et al., 2010).
Enkephalin binding to ∂-OR is greater than that for μ-OR
(Khachaturian et al., 1985; Raynor et al., 1994; Akil et al., 1998)
and dynorphin shows specific affinity for κ-OR (Chavkin et al.,
1982; Simon, 1991; Roth-Deri et al., 2008; Trigo et al., 2010).
Ethanol can modulate opioidergic transmission at different levels,
including synthesis, release, and degradation of opioid peptides,
and binding of endogenous ligands to OR (for a review see,
Méndez and Morales-Mulia, 2008). Since β-endorphin signaling
has been specially implicated in the behavioral effects of ethanol,
the present review will focus on the effects of ethanol on this
component of the EOS. In this regard, although OR and ligands
are widely distributed through the brain, there are important
neuroanatomical determinants related to β-endorphin distri-
bution that are worth highlighting. β-endorphin-synthesizing
cell bodies are primarily located in the hypothalamic arcuate
nucleus (NArc) (Chronwall, 1985). Important brain regions for
drug-induced effects such as the nucleus accumbens (NAcb)
are under tonic control of β-endorphinic innervations from the
NArc (Chronwall, 1985; Khachaturian et al., 1985; Spanagel et al.,
1992; Gianoulakis, 2001). These NArc β-endorphin projections
exert this control through the direct activation of OR located
at the NAcb and by an indirect pathway via OR in the ventral
tegmental area (VTA), which in turn modulate NAcb activity
via VTA-NAcb dopamine (DA) neurons (Mansour et al., 1988;
Di Chiara and North, 1992; Spanagel et al., 1992).
ETHANOL-INDUCED MODULATION OF β-ENDORPHINIC
NEUROTRANSMISSION
Acute administration of ethanol induces the release of β-
endorphin; an effect found in hypothalamic cell cultures and
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tissue preparations (Gianoulakis, 1990; Boyadjieva and Sarkar,
1994; de Waele et al., 1994; Reddy et al., 1995; De et al., 2002).
Ethanol also produces in vivo increases in β-endorphin con-
tent at the level of the hypothalamus (Schulz et al., 1980;
Patel and Pohorecky, 1989), NAcb (Anwer and Soliman, 1995;
Olive et al., 2001; Marinelli et al., 2003a), midbrain includ-
ing the VTA (Rasmussen et al., 1998; Jarjour et al., 2009)
and the central amygdala (CeA) (Lam et al., 2008). Some
studies, however, have found inconsistent results, proba-
bly related to procedural and methodological differences
(Seizinger et al., 1983; Popp and Erickson, 1998; Rasmussen et al.,
1998; Leriche and Méndez, 2010). Increased levels of enkephalin
in the hypothalamus (Schulz et al., 1980; Seizinger et al., 1983;
Milton et al., 1991) and NAcb (Marinelli et al., 2003b) have also
been found after acute ethanol.
Long-term exposure to ethanol primarily induces a
decrease in POMC expression (Boyadjieva and Sarkar, 1997;
Rasmussen et al., 2002; Oswald and Wand, 2004) and in hypotha-
lamic β-endorphin release and levels (Boyadjieva and Sarkar,
1994; Oswald and Wand, 2004). A limited number of studies
reported an increase in biosynthesis of POMC and POMCmRNA
expression (Seizinger et al., 1984; Gianoulakis et al., 1988) as
well as an initial increase followed by a gradual return to normal
levels (Wand, 1990). Also, some authors found an increase or
no effect on β-endorphin release (Boyadjieva and Sarkar, 1994;
Oswald and Wand, 2004). Discrepancies might be attributable
to the method of ethanol administration, ethanol dose, time
course of drug exposure, administration route and differences
in the development of tolerance. Also, it has been observed that
alcohol-induced changes depend on the brain region investigated
as well as the species and strain of animals used (Gianoulakis,
2001; Méndez and Morales-Mulia, 2008).
EVIDENCE OF BEHAVIORAL EFFECTS OF ETHANOL MEDIATED BY THE
ENDOGENOUS OPIOID SYSTEM
Given that β-endorphin, and also enkephalin, activate μ-OR,
extensive research has investigated the role of μ-OR in the
behavioral effects of ethanol (Gianoulakis, 1993; Herz, 1997;
Sanchis-Segura et al., 2000; Thorsell, 2013). Here we will focus
on the involvement of these components of the EOS in several
behavioral effects of ethanol, including psychomotor stimulation
and sensitization, consumption, and associative learning (with a
special focus on conditioned place preference (CPP)).
Psychomotor stimulation and sensitization
Increased psychomotor stimulation induced by ethanol in mice
can be blocked with non-selective opioid receptor antago-
nists such as naloxone or naltrexone (Kiianmaa et al., 1983;
Camarini et al., 2000; Sanchis-Segura et al., 2004; Pastor et al.,
2005; Pastor and Aragon, 2006). Some pharmacological strategies
have suggested the existence of three so-called subtypes of μ-
OR; μ1, μ2, and, μ3 (Pasternak, 2001a,b; Cadet et al., 2003) and
several studies have shown that μ- and specifically the μ1/2 -
and μ3-OR subtypes, but not δ- or κ-OR, are involved in the
motor stimulant effects of ethanol in adult mice (Pastor et al.,
2005), and also in rats during early development (Arias et al.,
2010; Pautassi et al., 2012). Other studies conducted in mice have
suggested that this involvement of μ-OR in ethanol stimulation
is debatable (Cunningham et al., 1998; Gevaerd et al., 1999;
Holstein et al., 2005). Consistent with the EOS involvement, how-
ever, a lesion of the NArc produces a decrease in ethanol-induced
stimulation in mice (Sanchis-Segura et al., 2000), and knock-
out mice deficient in β-endorphin showed attenuated ethanol-
induced stimulation (Dempsey and Grisel, 2012). Also, in rats,
naltrexone prevents activation produced by ethanol when locally
administered in the NArc (Pastor and Aragon, 2008) and intra-
VTA blockade of the μ-OR using either naltrexone or the irre-
versible and selective μ-OR antagonist β-funaltrexamine reduces
ethanol-induced locomotor stimulation (Sánchez-Catalán et al.,
2009). Additionally, chronic naltrexone, which upregulates μ-
OR (Unterwald et al., 1998; Lesscher et al., 2003), enhances the
stimulant effects of ethanol in mice (Sanchis-Segura et al., 2004).
A critical role of the EOS in the motor sensitizing effects
of ethanol has also been proposed (Camarini et al., 2000;
Miquel et al., 2003; Pastor and Aragon, 2006). Unspecific OR
antagonism prevents development (Camarini et al., 2000) but not
expression (Abrahao et al., 2008) of ethanol-induced locomotor
sensitization. μ-OR are particularly involved in ethanol sensiti-
zation (Camarini et al., 2000), without a clear role of any of the
μ-OR subtypes in mediating this process; μ1/2 -OR antagonism
slowed down, but did not block development of sensitization
(Pastor and Aragon, 2006). Facilitation of ethanol-induced sensi-
tization found after a period of voluntary alcohol consumption
in mice was also seen to be absent in μ-OR deficient CXBK
mice (Tarragón et al., 2012). The involvement ofμ-OR in ethanol
sensitization might be related to ethanol-induced increases in
β-endorphin release as a recent study demonstrated that β-
endorphin-deficient mice do not show locomotor sensitization
to ethanol (Dempsey and Grisel, 2012). Also, animals with selec-
tive lesions of the NArc show prevented sensitization to ethanol
(Miquel et al., 2003; Pastor et al., 2011). Altogether these data
suggest that opioids and specifically β-endorphins, via μ-OR,
might be critical mediators of ethanol-induced neuroplasticity
underlying psychomotor sensitization.
Ethanol consumption
Numerous studies conducted during the last few decades
showed that systemic, as well as local administration of
opioid antagonists decrease ethanol consumption under a
variety of schedules in different animal species (for reviews
see Herz, 1997; Gianoulakis, 2001; Oswald and Wand, 2004;
Modesto-Lowe and Fritz, 2005). These conclusions have also
been supported by the use of OR knockout mouse models
(Roberts et al., 2000; Méndez and Morales-Mulia, 2008). This
strong pre-clinical basis has lead to the use of opioid antago-
nists in alcoholism pharmacotherapy (O’Malley et al., 1992). In
rodents, the use of non-selective, as well as selective μ-OR antag-
onists proved to be effective at reducing ethanol consumption
(Méndez and Morales-Mulia, 2008). However, the effects of these
manipulations have been seen to be, in some cases, non-specific;
fat, saccharin, sucrose and water intake were also reduced by these
manipulations (Krishnan-Sarin et al., 1995; Nielsen et al., 2008;
Rao et al., 2008; Simms et al., 2008; Corwin and Wojnicki, 2009;
Wong et al., 2009). These data are compatible with the interpre-
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tation that OR, and especially μ-OR might be a key mediator of
the processing of positive reinforcement, both at emotional and
motivational levels (Herz, 1997; Peciña and Berridge, 2005).
In general, data obtained with κ-OR or δ-OR manipulations
are less conclusive. A recent review of the literature indicates
that κ-OR stimulation generally antagonizes the reinforcing
effects of alcohol whereas κ-OR blockade has no consistent
effect (Wee and Koob, 2010). Dynorphin/κ-OR system appears
to be involved in the negative reinforcing effects of ethanol by
producing an aversive effect rather than by directly modulat-
ing the rewarding mechanism of ethanol (Wee and Koob, 2010;
Walker et al., 2012). However, under an alcohol dependent-state,
antagonism of κ-OR results effective in decreasing ethanol vol-
untary consumption (Wee and Koob, 2010; Walker et al., 2012).
It has been reported that blockade of δ-OR either attenu-
ates (Lê et al., 1993; Froehlich, 1995; Krishnan-Sarin et al., 1995;
June et al., 1999; Hyytiä and Kiianmaa, 2001; Ciccocioppo et al.,
2002), increases (Margolis et al., 2008) or has no effect on ethanol
intake (Ingman et al., 2003). These discrepancies may be related
to dynamic changes in δ-OR efficacy during ethanol exposure
(Margolis et al., 2008). All these data support the participation of
the POMC and PENK systems in maintaining alcohol consump-
tion (Froehlich et al., 1991; Vengeliene et al., 2008).
Associative learning and conditioned place preference
It has been suggested that the EOS participates in the underlying
mechanisms mediating conditioned effects induced by abused
drugs, including ethanol. This implication is supported by two
groups of experiments. On one hand, evidence indicates that
OR antagonists attenuate cue-induced reinstatement of previ-
ously extinguished responding for ethanol self-administration
(Lê et al., 1999; Ciccocioppo et al., 2002, 2003; Liu and Weiss,
2002; Burattini et al., 2006; Dayas et al., 2007; Marinelli et al.,
2009), which suggests a role of EOS in cue-induced incen-
tive motivational effects influencing ethanol-seeking behavior.
This interpretation is consistent with clinical data showing that
opioid antagonists increase abstinence duration periods in alco-
hol abusers (O’Malley et al., 1992), probably by reducing cue-
induced seeking behavior. On the other hand, pretreatment
with opioid receptor antagonism, while not influencing the
acquisition of ethanol-induced CPP, reduces the expression and
facilitates the extinction of this drug-free conditioned response
(Bormann and Cunningham, 1997; Middaugh and Bandy, 2000;
Kuzmin et al., 2003; Pastor et al., 2011). Mice lacking μ-OR
also showed attenuated ethanol CPP (Hall et al., 2001). Further
studies have suggested that expression of ethanol-induced CPP
depends on OR located in the VTA, CeA, as well as anterior
cingulated cortex (Bechtholt and Cunningham, 2005; Bie et al.,
2009; Gremel et al., 2011). Additionally, a neurotoxic lesion of the
β-endorphin neurons of the NArc, showed a facilitated extinction
of ethanol-induced CPP (Pastor et al., 2011). β-endorphin andμ-
OR appear to be therefore critically involved in the mechanisms
underlying ethanol CPP. As Cunningham and collaborators have
suggested, it is possible that altered opioid signaling might in
turn alter conditioned motivation that normally maintains cue-
induced seeking behavior during CPP testing (Cunningham et al.,
1998). It is interesting to mention that pharmacological blockade
of δ-OR with naltrindole in the CeA reduces expression of CPP
induced by ethanol in rats (Bie et al., 2009). Activation of κ-OR
has been shown to blunt acquisition of ethanol CPP (Logrip et al.,
2009). Supporting these results, κ-OR knockoutmice also showed
enhanced ethanol CPP (Femenía and Manzanares, 2012).
ACETALDEHYDE: A PSYCHOACTIVE METABOLITE
The specific mechanism by which ethanol modulates the
activity of the EOS remains to be understood. Evidence
indicates that one possible mechanism might involve the role
of acetaldehyde, the first metabolite of ethanol (Miquel et al.,
2003; Sanchis-Segura et al., 2005b; Pastor and Aragon, 2008).
Acetaldehyde is a psychoactive compound that produces
behavioral and neurochemical effects suggested to mediate at least
some of the effects of ethanol. Acetaldehyde is self-administered
orally (Peana et al., 2010, 2012; Cacace et al., 2012) and
directly into the brain (Brown et al., 1979; McBride et al., 2002;
Rodd-Henricks et al., 2002; Peana et al., 2011). Its administration
induces CPP (Smith et al., 1984; Quertemont and De Witte,
2001; Peana et al., 2009; Spina et al., 2010) as well as behavioral
stimulation and sensitization when centrally administered
(Arizzi et al., 2003; Correa et al., 2003a,b, 2009; Rodd et al., 2005;
Arizzi-LaFrance et al., 2006; Sánchez-Catalán et al., 2009). The
oxidation of ethanol to acetaldehyde in the brain is essentially
mediated by the catalase-H2O2 system (Aragon et al., 1992a;
Gill et al., 1992). Reduced brain catalase activity, which have
been seen to decrease ethanol-derived central acetaldehyde
formation in brain tissue preparations (Hamby-Mason et al.,
1997) and in the brain of free-moving rats (Jamal et al., 2007),
decreases ethanol consumption (Aragon and Amit, 1992;
Koechling and Amit, 1994; Correa et al., 2004; Karahanian et al.,
2011), ethanol-induced locomotor stimulation (Aragon et al.,
1992b; Correa et al., 1999b, 2004; Sanchis-Segura et al., 1999a,b,c;
Pastor et al., 2002; Pastor and Aragon, 2008), the anxiolityc effects
of alcohol (Correa et al., 2008) and modulates ethanol-induced
CPP (Font et al., 2008). Strategies aimed at increasing the
production of brain acetaldehyde via an enhancement in activity
of the enzymatic catalase system have also been used. These
manipulations produced an increase in the motor stimulant
properties of ethanol in mice (Correa et al., 1999a, 2000;
Pastor et al., 2002). Other ethanol-induced effects such as taste
aversion (Aragon et al., 1985) and social memory recognition
have also been seen to be modulated by changes in brain catalase
(Manrique et al., 2005).
Apart from brain catalase manipulation, the direct inacti-
vation of acetaldehyde has also been shown to reduce ethanol
effects, including drinking (Font et al., 2006a) and alcohol-
induced relapse drinking (Orrico et al., 2013), CPP (Font et al.,
2006b; Peana et al., 2008) and motor stimulation (Font et al.,
2005; Martí-Prats et al., 2010; Pautassi et al., 2011).
ACETALDEHYDE-INDUCED CHANGES IN THE OPIOIDERGIC
NEUROTRANSMISSION
The NArc, the main site of β-endorphin synthesis in the brain,
is one of areas with the highest levels of catalase expression
(Moreno et al., 1995; Zimatkin and Lindros, 1996) and lower
levels of the acetaldehyde-degrading enzyme aldehyde dehydroge-
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nase (Zimatkin et al., 1992). Therefore, it has been thus suggested
that catalase-dependent formation of acetaldehyde into the NArc
might mediate ethanol-induced increases in the release of β-
endorphin from the NArc in turn activating OR at the level of
the VTA/NAcb to stimulate behavioral and neurophysiological
actions (Sanchis-Segura et al., 2005a; Pastor and Aragon, 2008).
Supporting this hypothesis, several authors (Reddy and Sarkar,
1993; Pastorcic et al., 1994; Reddy et al., 1995) have demonstrated
that ethanol-induced increases in hypothalamic β-endorphin
release are, indeed, mediated by acetaldehyde (Reddy and Sarkar,
1993; Pastorcic et al., 1994; Reddy et al., 1995). Hypothalamic
cell cultures exposed to ethanol (12.5–100 μM) led to the
formation of acetaldehyde (8–24 μM) and similar concentra-
tions of acetaldehyde (12.5–50 μM) were able to stimulate
β-endorphin release when tested in the absence of ethanol
(Reddy and Sarkar, 1993; Pastorcic et al., 1994). Moreover, pre-
treatment of hypothalamic cell cultures with catalase inhibitors
caused dose-dependent decreases in ethanol-stimulated β-
endorphin secretion (Reddy et al., 1995).
Another line of research linking the EOS and acetaldehyde
is the investigation of the actions of salsolinol (for a review
see Hipólito et al., 2012), the condensation product of DA and
acetaldehyde. Salsolinol has been shown to alter enkephalin-
receptor site binding (Lucchi et al., 1982) and other OR an
effect that is blocked by naloxone (Fertel et al., 1980). Inter-
estingly, intra-NAcb administration of salsolinol increases DA
levels when microinjected in the core and decreases DA lev-
els if the administration is in the NAcb shell (Hipólito et al.,
2009) in a similar way to μ- and δ-OR agonists (Hipólito et al.,
2008). It has been demonstrated that μ1-OR receptors exert
a tonic modulatory control over activity of the DA system
(Di Chiara and North, 1992; Devine et al., 1993). Thus, one pos-
sible mechanism by which salsolinol exerts its effects on the
OR could be disinhibiting DA neurons in the VTA. Uphold-
ing this hypothesis, intra-posterior VTA administration of sal-
solinol induces a μ-OR dependent increase in DA levels in
the NAcb shell (Hipólito et al., 2011). Accordingly, it has been
recently shown that salsolinol excites DA neurons of the VTA,
by activating μ-OR on local GABA interneurons (Xie et al.,
2012).
EVIDENCE OF BEHAVIORAL EFFECTS OF ACETALDEHYDE MEDIATED BY
THE ENDOGENOUS OPIOID SYSTEM
Whereas accumulating evidence indicates that the EOS par-
ticipates in the behavioral effects of ethanol, only few stud-
ies have studied the involvement of this system in acetaldehyde
effects. Self-administration of acetaldehyde appears to be medi-
ated by the EOS; high doses of naloxone reduced intravenous
acetaldehyde self-administration in rats, and naltrexone reduced
the maintenance, the deprivation effect, and operant break
points of acetaldehyde voluntary consumption (Myers et al., 1984;
Peana et al., 2011). Treatment with naloxonazine, a specific μ1-
OR antagonist reduces maintenance of acetaldehyde oral self-
administration (Peana et al., 2011). Blockade of μ-OR using
either naltrexone or the irreversible and selective μ-OR antago-
nist β-funaltrexamine suppress the locomotor stimulation effect
of acetaldehyde when microinjected into the rat posterior VTA
(Sánchez-Catalán et al., 2009). Additionally, Hipólito et al. (2010)
have provided data supporting the hypothesis that acetalde-
hyde may mediate the actions of ethanol through a mechanism
dependent on μ-OR activation. These authors showed that intra-
posterior VTA injections of salsolinol induced locomotor stimu-
lation and sensitization in rats; stimulation (but not sensitization)
was prevented byμ-OR antagonism. Finally, Sanchis-Segura et al.
(2005b) demonstrated that administration of a catalase inhibitor
directly into the NArc is sufficient to prevent the effects of ethanol
on rat locomotion. Conversely, locomotor stimulation induced by
ethanol injected directly into the NArc, was prevented by cata-
lase inhibition or naltrexone, indicating a link between the behav-
ioral effects of a reduction in acetaldehyde formation and the
antagonism ofμ-OR (Pastor and Aragon, 2008). TheNArc, there-
fore, may represent a critical site to link two independent but
related hypotheses: (1) the hypothesis proposing that acetalde-
hyde may mediate some of the psychopharmacological actions
attributed to ethanol (Aragon et al., 1992a; Smith et al., 1997;
Quertemont et al., 2005; Correa et al., 2012) and (2) the hypothe-
sis that suggests that the β-endorphin/μ-OR system participate in
the reinforcing and psychomotor effects of ethanol (Stinus et al.,
1980; Herz, 1997; Gianoulakis, 2001; Sanchis-Segura et al., 2005b;
Pastor and Aragon, 2008). Early findings also suggested a role
of the opioidergic system in mediating CPP induced by sal-
solinol in rats (Matsuzawa et al., 2000). Antagonism of μ-OR
attenuated CPP induced by salsolinol when achieved under fear
stress (Matsuzawa et al., 2000). Moreover, intra-posterior VTA
administration of salsolinol, that produced CPP in rats, also
produced an increase in DA in the NAcb that was suppressed by
β-funaltrexamine administration (Hipólito et al., 2011).
SUMMARY AND PERSPECTIVES
In the present review we have summarized consistent results
indicating that the EOS, and particularly β-endorphin and μ-
OR, are critically involved in the psychopharmacological effects
of ethanol. Additionally, we have reviewed a large body of data
that indicates that the first metabolite of ethanol, acetaldehyde,
might be responsible for the activation of β-endorphin release
and μ-OR signaling after ethanol administration. There are two
main lines of research suggesting a link between acetaldehyde and
the EOS: (1) formation of acetaldehyde in brain areas such as
the NArc, with high expression of ethanol metabolizing enzymes
and presence of cell bodies of endorphinic neurons and (2) the
formation of condensation products between DA and acetalde-
hyde such as salsolinol, which exerts its actions via μ-OR. To
a certain degree both lines of research show important incom-
patibility. The fact that the lesions of the NArc are sufficient
to block ethanol-induced behaviors challenge the putative role
of salsolinol formed in other non-hypothalamic areas. Future
studies will need to explore how to reconcile those two sets
of data, and to clarify what is sufficient and/or necessary for
acetaldehyde to induce behavioral responsesmediated by the EOS.
Finally, it is interesting to mention that most of the data sug-
gesting a role of the EOS in acetaldehyde-induced behavioral
effects have been linked to acetaldehyde-induced changes in the
opioid system that are suggested to impact behavior via mod-
ulation of the DA system (Peana et al., 2011). Ethanol as well
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as acetaldehyde activate firing of dopaminergic neurons in the
VTA (Foddai et al., 2004; Diana et al., 2008) and stimulate DA
transmission in the NAcb (Melis et al., 2007; Enrico et al., 2009;
Sirca et al., 2011), effects that are prevented by D-penicillamine,
a sequestering agent of acetaldehyde (Enrico et al., 2009). A
recent study demonstrates that in rats, ethanol and acetalde-
hyde induce via DA D1 receptors, ERK phosphorylation in the
NAcb and extended amygdala (Vinci et al., 2010). This effect
is blocked by D-penicillamine and by naltrexone, suggesting
that the opiodergic modulation of the reinforcing properties of
acetaldehyde could be mediated by the dopaminergic system
(Vinci et al., 2010; Peana et al., 2011). There are other effects
such as ethanol-induced CPP, ethanol drinking in some non-
operant conditions and even ethanol-induced sensitization that
appear to have a less straightforward involvement of DA sig-
naling (Risinger et al., 1992; Broadbent et al., 1995; Spina et al.,
2010; Young et al., 2013). Future research will need to investigate
DA-dependent and independent mechanisms by which acetalde-
hyde might induce behavioral responses via its modulation of
the EOS.
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